Peter W. Groeneveld, MD, MS
Peter W. Groeneveld, MD, MS
Center for Health Equity Research and Promotion
Philadelphia, PA
Find citations from this investigator | Find recent studies by this investigator
Peter W. Groeneveld, M.D., M.S. completed his undergraduate degree (S.B.) in engineering sciences at Harvard University in 1991, his medical training at Tufts University in 1995, his residency in internal medicine at the University of California-San Francisco in 1998, and fellowship training and a Masters degree in health services research at Stanford University in 2003. He joined the VA in 1998 and moved from the San Francisco to the Philadelphia VAMC in 2003.
Dr. Groeneveld's major research interests are medical technology assessment and the diffusion of innovation in health care. He currently is principal investigator on a 3-year study funded by the Institute for Health Technology Studies-a non-profit research foundation-to examine the costs and quality-of-life outcomes of innovative cardiovascular device therapies. Dr. Groeneveld's HSR&D career development award enables him to pursue his interests in technology diffusion within the VA context, with an emphasis on economic and equity implications. In pursuit of these interests, he recent completed a pilot project examining racial differences in veterans' attitudes to innovative, high-technology therapies (published in the Journal of General Internal Medicine, June, 2006), and a second project evaluating differences in utilization rates of cardiovascular therapies among VAMCs nationwide (publication pending in the American Heart Journal, 2007). He is also using the VA's Decision Support System databases to evaluate the costs of innovation within VA. Dr. Groeneveld is a core faculty member of the VA's Center for Health Equity Research and Promotion, a member of the Executive Committee of the VA's Congestive Heart Failure Quality Enhancement Research Initiative, and a member of the American College of Cardiology's National Cardiovascular Data Registry Implantable Cardioverter-Defibrillator Research and Publications Subcommittee.
Dr. Groeneveld's other recent publications include, "Costs and quality-of-life effects of implantable cardioverter-defibrillators" in the November 15, 2006 issue of the American Journal of Cardiology, as well as a pending publication, "Quality of life among implantable cardioverter-defibrillator recipients in the primary prevention therapeutic era," to appear in Pacing and Clinical Electrophysiology (2007).
Dr. Groeneveld's mentors are David Asch, M.D., M.B.A., a nationally recognized leader in clinician and patient behavior and decision-making, J. Sanford Schwartz, M.D., a distinguished expert in technology assessment and diffusion of innovation, and Mark Pauly, Ph.D., a world-renowned health economist.